WHO Issues Global Medical Alert For Contaminated Batch of Punjab Manufactured Cough Syrup
The World Health Organisation (WHO) has issued a global medical alert for a cough syrup produced by Punjab-based QP Pharmachem and marketed by Haryana-based Trillium Pharma. The cough syrup was flagged in the Western Pacific Region but the organization has not shared if anyone has fallen sick.
The cough syrup named Guaifenesin Syrup TG Syrup has been flagged by WHO because of a batch that is said to be substandard (contaminated). The batch was found in the Marshall Islands and Micronesia, and was reported to WHO on April 6, 2023. It explained that samples of Guaifenesin Syrup TG Syrup from the Marshall Islands were analysed by quality control laboratories of the Therapeutic Goods Administration (TGA) of Australia and they were found to contain contaminants diethylene glycol and ethylene glycol.
Diethylene glycol and ethylene glycol are toxic to humans and can prove fatal when consumed.